Gliosarcoma WHO Grade IV-Giant Cell Glioblastoma WHO Grade IV

Weis, Serge; Sonnberger, Michael; Dunzinger, Andreas; Voglmayr, Eva; Aichholzer, Martin; Kleiser, Raimund; Strasser, Peter

doi:10.1007/978-3-7091-1544-2_55

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the limitations of MRI in distinguishing morphological subtypes, subtle variations contribute to their overall diversity on imaging. For instance, giant cell glioblastomas and gliosarcomas can present with more circumscribed lesions located subcortically, resembling metastasis or meningiomas [ 89 , 90 , 91 , 92 ].…”

Section: Glioblastoma Idh-wildtypementioning

confidence: 99%

The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas

Gue,

Lakhani

2024

Biomedicines

View full text Add to dashboard Cite

The 2021 edition of the World Health Organization (WHO) classification of central nervous system tumors introduces significant revisions across various tumor types. These updates, encompassing changes in diagnostic techniques, genomic integration, terminology, and grading, are crucial for radiologists, who play a critical role in interpreting brain tumor imaging. Such changes impact the diagnosis and management of nearly all central nervous system tumor categories, including the reclassification, addition, and removal of specific tumor entities. Given their pivotal role in patient care, radiologists must remain conversant with these revisions to effectively contribute to multidisciplinary tumor boards and collaborate with peers in neuro-oncology, neurosurgery, radiation oncology, and neuropathology. This knowledge is essential not only for accurate diagnosis and staging, but also for understanding the molecular and genetic underpinnings of tumors, which can influence treatment decisions and prognostication. This review, therefore, focuses on the most pertinent updates concerning the classification of adult diffuse gliomas, highlighting the aspects most relevant to radiological practice. Emphasis is placed on the implications of new genetic information on tumor behavior and imaging findings, providing necessary tools to stay abreast of advancements in the field. This comprehensive overview aims to enhance the radiologist’s ability to integrate new WHO classification criteria into everyday practice, ultimately improving patient outcomes through informed and precise imaging assessments.

show abstract